Nexgel (NXGL) Other Non-Current Liabilities (2018 - 2024)
Nexgel (NXGL) posted Other Non-Current Liabilities of $178000.0 for Q4 2024, down 34.32% on a QoQ basis from $271000.0 in Q3 2024, and down 59.45% year-over-year from $439000.0 in Q1 2024.
Nexgel (NXGL) Other Non-Current Liabilities (2018 - 2024) Analysis & Trends
Nexgel's Other Non-Current Liabilities history runs 3 years deep, the most recent figure standing at $178000.0 for Q4 2024.
- Quarterly Other Non-Current Liabilities fell 59.45% year-over-year to $178000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $178000.0 (down 59.45% YoY) and the FY2024 annual result came in at $178000.0, down 59.45% from the prior year.
- Other Non-Current Liabilities was $178000.0 for Q4 2024 at Nexgel, down from $271000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $439000.0 in Q4 2023 and bottomed at $178000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Nexgel | 3.50 Mn | 2.13 Mn | 819,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 178,000.00 |
| Sep 30, 2024 | 271,000.00 |
| Jun 30, 2024 | 370,000.00 |
| Mar 31, 2024 | 439,000.00 |
| Dec 31, 2023 | 439,000.00 |
| Dec 31, 2018 | 51,000.00 |